A Class II medical device is a product that poses a moderate risk to patients or users and requires specific safety controls beyond basic manufacturing standards before it can be sold. The FDA uses a three-tier classification system based on risk, and Class II sits in the middle. It covers the largest category of medical devices on the market, including everything from powered wheelchairs and pregnancy tests to contact lenses and surgical drapes.
How the FDA Classifies Medical Devices
The FDA assigns every medical device to one of three classes based primarily on how much risk it poses to the patient or the person using it. Class I covers the lowest-risk devices, things like tongue depressors, elastic bandages, and manual stethoscopes. Class III covers the highest-risk devices, such as pacemakers, heart valves, and implantable defibrillators. Class II falls between those two extremes.
What separates Class II from Class I isn’t just risk level. It’s the type of oversight the FDA considers necessary. Class I devices only need “general controls,” which are baseline requirements like proper labeling, manufacturing standards, and registering with the FDA. Class II devices need those same general controls plus an additional layer called “special controls.” These are tailored requirements designed to address the specific risks a particular type of device presents. Special controls can include performance testing standards, specific labeling requirements, postmarket surveillance, or design guidelines unique to that device category.
Class III devices go further still, requiring the most rigorous pathway: full premarket approval with clinical trial data proving the device is safe and effective.
Common Examples of Class II Devices
Class II is by far the broadest category in the FDA’s system. Some familiar examples include:
- Diagnostic devices: pregnancy test kits, blood pressure monitors, glucose meters
- Imaging equipment: X-ray machines, ultrasound systems, MRI coils
- Surgical tools: powered surgical instruments, surgical drapes, certain catheters
- Mobility and rehab: powered wheelchairs, hearing aids, infusion pumps
- Vision correction: contact lenses, certain types of intraocular lenses
The common thread is that these devices carry real but manageable risks. A blood pressure monitor that gives inaccurate readings could lead to missed diagnoses. A faulty infusion pump could deliver too much or too little medication. The FDA considers these risks serious enough to warrant extra oversight but not so high that each individual product needs a full clinical trial before reaching the market.
The 510(k) Clearance Process
Most Class II devices reach the market through a regulatory pathway called a 510(k) premarket notification. This is not the same as an “approval,” and the distinction matters. Instead of proving a device is safe and effective from scratch, the manufacturer demonstrates that their device is “substantially equivalent” to a device already legally sold in the U.S. That existing device is called a predicate.
To show substantial equivalence, the manufacturer must prove two things: the new device has the same intended use as the predicate, and it either uses the same technology or, if the technology differs, it doesn’t raise new safety concerns. Supporting this claim typically requires submitting performance data. That can include engineering bench tests, biocompatibility evaluations, software validation, electromagnetic compatibility testing, sterility data, and sometimes clinical data.
The FDA’s target review time for a 510(k) submission is 90 FDA days. That clock excludes any periods where the FDA pauses the review to request additional information from the manufacturer, so the real-world timeline from submission to clearance is often longer. A 510(k) is also required when a manufacturer makes changes to an already-cleared device that could significantly affect its safety or how well it works.
Not every Class II device needs a 510(k). Some are specifically exempt from this requirement under the FDA’s classification regulations, though they still must comply with general and special controls.
What a 510(k) Costs
The FDA charges user fees for 510(k) submissions. For fiscal year 2025, the standard fee is $24,335. Small businesses pay a reduced rate of $6,084. These fees cover only the FDA’s review. The total cost of bringing a Class II device to market is significantly higher when you factor in the testing, documentation, quality system compliance, and design controls that manufacturers are required to maintain throughout development and production.
Special Controls and Quality Requirements
The “special controls” that define Class II regulation are not one-size-fits-all. The FDA publishes guidance documents for specific device types, each outlining the particular risks that device poses and the controls needed to manage them. For one type of device, that might mean mandatory performance benchmarks. For another, it could require specific patient labeling or electromagnetic interference testing.
On top of special controls, all Class II device manufacturers must follow design controls during product development. These are formal procedures requiring manufacturers to document every stage of the design process, from initial planning through verification and validation. The goal is to ensure that the device consistently meets its intended specifications and that potential problems are identified before the product reaches patients.
How Other Countries Classify These Devices
The European Union uses a similar but not identical system under its Medical Device Regulation. Where the FDA has a single Class II, the EU splits the middle tier into two subcategories. Class IIa covers low-to-medium risk devices, generally those placed inside the body for short periods (between 60 minutes and 30 days). Class IIb covers medium-to-high risk devices, often those implanted for 30 days or longer. Both require a conformity assessment by an independent body, with Class IIb implantable devices facing additional scrutiny of their technical documentation.
A device classified as Class II in the U.S. won’t necessarily fall into the same tier in Europe. Manufacturers selling internationally need to navigate both systems independently, meeting the specific requirements of each regulatory authority.